Expediting lentiviral vector development with automated bioreactors and design of experiments

被引：0
作者：
Watt, F. [2 ]
Ede, D. [3 ]
Roberto, M. [3 ]
Geiger, S. [2 ]
Kwok, A. [2 ]
Traul, D. [3 ]
Lam, V. [3 ]
Chew, E. [3 ]
Warner, M. [3 ]
Schulze, E. A. [1 ]
Bollmann, F. [1 ]
Gustafson, J. [2 ]
Jensen, M. [2 ]
机构：
[1] Sartorius Stedim GmbH, Aubagne, France
[2] Seattle Childrens Res Inst, Seattle, WA USA
[3] Sartorius North Amer, Ann Arbor, MI USA
来源：
HUMAN GENE THERAPY | 2024年 / 35卷 / 3-4期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P247
引用
收藏
页码：A126 / A126
页数：1
相关论文
共 50 条
  • [31] Development of a successful lyophilization process for lentiviral vector clinical batches
    Peral, F.
    Delacroix, N.
    Deroyer, J.
    Deplaine, G.
    Bejanariu, A.
    Hadri, A.
    Bauche, C.
    HUMAN GENE THERAPY, 2015, 26 (10) : A69 - A69
  • [32] Lentiviral vector transduction of spermatozoa as a tool for the study of early development
    Chandrashekran, Anil
    Isa, Ihsan
    Dudhia, Jayesh
    Thrasher, Adrian J.
    Dibb, Nicholas
    Casimir, Colin
    Readhead, Carol
    Winston, Robert
    FEBS OPEN BIO, 2014, 4 : 266 - 275
  • [33] The Use of Automation in the Development of Lentiviral Vector Producer Cell Lines
    Clarkson, Nicholas
    Farley, Daniel
    Stewart, Hannah
    Dunne, Laura
    Nogueira, Cristina
    Hood, Alasdair
    Maunder, Helen
    Pearson, Laura
    Boura, Joana
    Knevelman, Carol
    Miskin, James
    Mitrophanous, Kyriacos
    MOLECULAR THERAPY, 2018, 26 (05) : 288 - 288
  • [34] Development of a Successful Lyophilization Process for Lentiviral Vector Clinical Batches
    Delacroix, Nicolas
    Mbele, Gael Ouengue
    Deroyer, Julien
    Deplaine, Guillaume
    Bauche, Cecile
    MOLECULAR THERAPY, 2015, 23 : S267 - S267
  • [35] Development of an EIAV based lentiviral vector producer cell line
    Stewart, Hannah
    Mitrophanous, Kyriacos
    Radcliffe, Pippa
    HUMAN GENE THERAPY, 2008, 19 (10) : 1166 - 1166
  • [36] Development of a physiologically regulated lentiviral vector for the treatment of ischaemic diseases
    Binley, K
    Esapa, M
    Iqball, S
    Naylor, S
    JOURNAL OF GENE MEDICINE, 2004, 6 (09) : S38 - S38
  • [37] Expediting the Design, Discovery and Development of Anticancer Drugs using Computational Approaches
    Basith, Shaherin
    Cui, Minghua
    Macalino, Stephani J. Y.
    Choi, Sun
    CURRENT MEDICINAL CHEMISTRY, 2017, 24 (42) : 4753 - 4778
  • [38] Modular Lentiviral Vector System for Chimeric Antigen Receptor Design Optimization
    Kulemzin, S. V.
    Chikaev, N. A.
    Volkova, O. Y.
    Kuznetsova, V. V.
    Taranin, A. V.
    Gorchakov, A. A.
    RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2017, 43 (02) : 107 - 114
  • [39] The genotoxic potential of lentiviral vector integration is modulated by the interplay between vector design and mouse genotype
    Cesana, D.
    Ranzani, M.
    Volpin, M.
    Bartholomae, C.
    Merella, S.
    Benedicenti, F.
    Sergi, L. Sergi
    SanVito, F.
    Brombin, C.
    Nonis, A.
    Di Serio, C.
    Doglioni, C.
    VonKalle, C.
    Schmidt, M.
    Naldini, L.
    Montini, E.
    HUMAN GENE THERAPY, 2013, 24 (12) : A151 - A151
  • [40] Modular lentiviral vector system for chimeric antigen receptor design optimization
    S. V. Kulemzin
    N. A. Chikaev
    O. Y. Volkova
    V. V. Kuznetsova
    A. V. Taranin
    A. A. Gorchakov
    Russian Journal of Bioorganic Chemistry, 2017, 43 : 107 - 114
12345